Based on 3 analysts offering 12 month price targets for Kailera Therapeutics Inc
Min Forecast
$30.00+54.88%
Avg Forecast
$38.00+96.18%
Max Forecast
$48.00+147.81%
Should I buy or sell KLRA stock?
Based on 3 analysts offering ratings for Kailera Therapeutics Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although KLRA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates KLRA as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More
Be the first to know when Wall Street analysts revise their KLRA stock forecasts and price targets.
Is Kailera Therapeutics Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: KLRA) stock is to Strong Buy KLRA stock.
Out of 3 analysts, 2 (66.67%) are recommending KLRA as a Strong Buy, 1 (33.33%) are recommending KLRA as a Buy, 0 (0%) are recommending KLRA as a Hold, 0 (0%) are recommending KLRA as a Sell, and 0 (0%) are recommending KLRA as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year KLRA price target, the average KLRA price target is $38.00, with the highest KLRA stock price forecast at $48.00 and the lowest KLRA stock price forecast at $30.00.
On average, Wall Street analysts predict that Kailera Therapeutics's share price could reach $38.00 by May 12, 2027. The average Kailera Therapeutics stock price prediction forecasts a potential upside of 96.18% from the current KLRA share price of $19.37.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.